-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS Q2 FY26 GAAP EPS more than doubled to $2.31; revenue rises 7.3% to $106.1 billion

PUBT·08/05/2026 10:36:33
Listen to the news
CVS Q2 FY26 GAAP EPS more than doubled to $2.31; revenue rises 7.3% to $106.1 billion
  • CVS Health Q2 2026 revenue rose 7.3% to USD 106.1 billion; GAAP diluted EPS more than doubled to USD 2.31.
  • GAAP operating income climbed 97.5% to USD 4.7 billion; GAAP net income rose to USD 3 billion.
  • Adjusted EPS increased to USD 2.58; driven primarily by improved adjusted operating income in Health Care Benefits.
  • Health Care Benefits medical benefit ratio narrowed 2.5 percentage points to 87.4%; segment adjusted operating income rose to USD 2.43 billion.
  • Raised full-year 2026 GAAP diluted EPS view to USD 6.84-7.04; adjusted EPS to USD 7.9-8.1, cash flow from operations to at least USD 11.5 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608050630PR_NEWS_USPR_____NE19231) on August 05, 2026, and is solely responsible for the information contained therein.